Sign Up to like & get
recommendations!
1
Published in 2022 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.51670
Abstract: Concentrations of amyloid‐β peptides (Aβ42/Aβ40) and neurofilament light (NfL) can be measured in plasma or cerebrospinal fluid (CSF) and are associated with Alzheimer’s disease brain pathology and cognitive impairment. This study directly compared plasma and…
read more here.
Keywords:
plasma csf;
cognitive decline;
csf;
comparison plasma ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Molecular Neurobiology"
DOI: 10.1007/s12035-021-02625-1
Abstract: The existence of few biomarkers and the lack of a better understanding of the pathophysiology of levodopa-induced dyskinesia (LID) in Parkinson’s disease (PD) require new approaches, as the metabolomic analysis, for discoveries. We aimed to…
read more here.
Keywords:
metabolic profile;
plasma csf;
cohort;
plasma ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Journal of Neuroinflammation"
DOI: 10.1186/s12974-021-02145-8
Abstract: Background Our understanding of the relationship between plasma and cerebrospinal fluid (CSF) remains limited, which poses an obstacle to the identification of blood-based markers of neuroinflammatory disorders. To better understand the relationship between peripheral and…
read more here.
Keywords:
plasma csf;
surgery;
plasma;
po1mo ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Clinical Interventions in Aging"
DOI: 10.2147/cia.s388690
Abstract: Objective This study aimed to explore possible biomarkers of postoperative delirium (POD) of Parkinson’s disease (PD) patients received deep brain stimulation (DBS) of the subthalamic nuclei. Materials and methods This nested case control study analyzed…
read more here.
Keywords:
plasma csf;
pod;
concentration;
biomarkers postoperative ... See more keywords